Related Experiment Video
Updated: May 12, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Disseminated Aspergillosis due to Aspergillus niger in Immunocompetent Patient: A Case Report
Ulku Ergene1, Zeynep Akcali, Demircan Ozbalci
1Department of Hematology, Medical Faculty, Celal Bayar University, Manisa, Turkey.
Abstract:
Invasive aspergillosis is a major cause of morbidity and mortality in immunocompromised patients. Many cases of pulmonary, cutaneous, cerebral, and paranasal sinus aspergillosis in immunocompetent patient were defined in literature but disseminated aspergillosis is very rare. Here we present an immunocompetent case with extrapulmonary disseminated aspergillosis due to Aspergillus niger, totally recovered after effective antifungal treatment with voriconazole.
Insights
Disseminated aspergillosis, a rare infection in immunocompetent individuals, was successfully treated. This case highlights effective antifungal therapy for invasive Aspergillus niger infection in an immunocompetent patient.
Area of Science:
- Mycology
- Infectious Diseases
- Clinical Medicine
Background:
- Invasive aspergillosis commonly affects immunocompromised patients, leading to significant morbidity and mortality.
- While localized forms (pulmonary, cutaneous, cerebral, paranasal sinus) are documented in immunocompetent individuals, disseminated disease remains exceptionally rare.
Purpose of the Study:
- To report a rare case of extrapulmonary disseminated aspergillosis in an immunocompetent patient.
- To emphasize the successful management of invasive Aspergillus niger infection with voriconazole.
Main Methods:
- Case presentation of an immunocompetent individual diagnosed with disseminated aspergillosis.
- Treatment with voriconazole, a broad-spectrum antifungal agent.
Main Results:
- The patient, despite being immunocompetent, developed disseminated Aspergillus niger infection.
- Complete recovery was achieved following targeted antifungal treatment with voriconazole.
Conclusions:
- Extrapulmonary disseminated aspergillosis can occur in immunocompetent individuals, although rare.
- Voriconazole is an effective treatment option for invasive Aspergillus niger infections, even in the absence of traditional risk factors.
Related Concept Videos
Fungal Phylum Ascomycota
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Fungal Phylum Microsporidia